Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease

Crohn Disease Clinical Trial

Official title: Clinical Trial to Evaluate the Effect of an Oligomeric Oral Nutritional Supplement on the Response in Intestinal Absorption and Inflammation, in Patients With CROHN Disease

Status Recruiting

Clinical Trial Summary

This is a randomized, multicenter, translational, triple-blind, clinical trial in patients with Crohn's disease, who will be prescribed an oral nutritional supplement to control symptoms in the acute phase and to recover in the remission phase.

Clinical Trial Description

Multicentric, parallel, randomized, double blind and controlled clinical-nutritional study of 6 months of intervention and 3 study groups of treatment: Experimental group (peptidic diet with a mix of probiotics); Experimental group with placebo (peptidic diet with a placebo); and Control group (control with a polymeric nutritional oral supplement with a placebo) to evaluate the effect on the nutritional status, inflammatory markers and the intestinal absorption ;

Related Conditions & MeSH terms

• Absorption; Disorder
• Absorption; Disorder, Carbohydrate
• Absorption; Disorder, Fat
• Absorption; Disorder, Protein
• Crohn Disease
• Disease
• Malnutrition

• NCT number: NCT04305535
• Study type: Interventional
• Source: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
• Contact: Miguel A Aganzo-Yeves, RD
• Phone: +34661774925
• Email: miguel.aganzo@fjd.es
• Status: Recruiting
• Phase: N/A
• Start date: February 13, 2020
• Completion date: June 2021